Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Notably, only one registered clinical study exists to date, which evaluates an implant-based delivery system of Exenatide and is currently in Phase 1 with an Active, not recruiting status (NCT05670379), initiated on December 20, 2024, and expected to conclude by August 2025
This plan should include a focus on nutrition, regular exercise, and a system for accountability
Drinking water soon after waking helps replenish fluids, supports digestion, and prepares your body for the day ahead
The investigational status of retatrutide and the limited population size of pre-Phase-3 trials mean less is known about long-term and rare adverse events than for FDA-approved tirzepatide or semaglutide
US$ 25.26
US$ 28.31
US$ 23.10
